Mode
Text Size
Log in / Sign up

Adenocarcinoma

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Adenocarcinoma

30 trials tracked for Adenocarcinoma: 6 in phase 3 or 4.

30Trials tracked
6Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 5 Phase 2 17 Phase 1 3 Other / NA 4
  1. Phase 4 Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly Completed
  2. Phase 3 Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix Completed
  3. Phase 3 Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma Completed
  4. Phase 3 BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation Completed
  5. Phase 3 BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC) Completed
  6. Phase 3 A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer Completed
Show 24 more trials
  1. Phase 2 A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. Completed
  2. Phase 2 Trial of Curcumin in Advanced Pancreatic Cancer Completed
  3. Phase 2 Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung Completed
  4. Phase 2 PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer Completed
  5. Phase 2 A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer Completed
  6. Phase 2 A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Completed
  7. Phase 2 Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study Completed
  8. Phase 2 Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors Completed
  9. Phase 2 Combination Immunotherapy of GM.CD40L Vaccine With CCL21 in Lung Cancer Completed
  10. Phase 2 RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe Completed
  11. Phase 2 Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors Completed
  12. Phase 2 Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma Completed
  13. Phase 2 Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) Completed
  14. Phase 2 PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression Completed
  15. Phase 2 A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer Completed
  16. Phase 2 Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer Completed
  17. Phase 2 Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO) Completed
  18. Phase 1 Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC Completed
  19. Phase 1 Cancer Vaccine Targeting Brachyury Protein in Tumors Completed
  20. Phase 1 Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas Completed
  21. N/A CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia Completed
  22. N/A Detection Of Neoplastic Tissue in Barrett's Esophagus With In vivO Probe-based Confocal Endomicroscopy Completed
  23. N/A Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC Completed
  24. N/A Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) Completed

Showing the 30 most-cited and recently-updated of 30 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.